-
Psilocybin-assisted therapy bests nicotine patch for smoking cessation in pilot study
At six months following the target quit date, 40.5% of participants in the psilocybin group achieved biochemically verified prolonged abstinence compared with only 10.0% in the nicotine patch group.
Recent News
-
Industry Supported
|
-
LGBTQ+ health in focus: A Pride Month call to action
Let us recommit to a principle of care that surpasses clinical excellence; one that is inclusive, compassionate, and just.
-
Top reads from the CHEST journal portfolio – May 2026
Read new research from the journal portfolio on proximal hypoglossal nerve stimulation, shared decision-making in lung cancer screening, and lactate clearance in postoperative cardiac surgery care.
-
Advocating for change based on pulse oximetry research
Thomas Valley, MD, MS, shares how he advocates for systemwide change based on his research in pulse oximeter inaccuracies due to skin tone and encourages other clinicians to ask important questions that will improve patient care.
-
Advancing excellence: Why I pursued the CHEST CCAPP certification
The CCAPP certification demonstrates not only competence but also commitment to patients, teams, and the profession.
-
When oil infrastructure burns: What pulmonary clinicians should know
Recent conflict in the Middle East sheds light on oil fires as respiratory exposure events. Pulmonary clinicians need to be prepared to treat both acute and chronic symptoms from these exposures.
-
Navigating normotensive shock
Authors discuss the role normotensive shock plays in PE risk stratification according to new AHA guidelines on PE classification and management.
